Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-13,715
Closed -$1.65M 92
2026
Q1
$1.65M Sell
13,715
-9,932
-42% -$1.15M 0.07% 45
2025
Q4
$2.49M Buy
23,647
+17,496
+284% +$1.64M 0.13% 27
2025
Q3
$516K Buy
+6,151
New +$507K 0.06% 48
2024
Q2
Sell
-8,783
Closed -$1.16M 25
2024
Q1
$1.16M Buy
+8,783
New +$1.08M 0.2% 9
2021
Q2
Sell
-499
Closed -$37.1K 288
2021
Q1
$37K Sell
499
-1,093
-69% -$80.6K ﹤0.01% 214
2020
Q4
$124K Buy
+1,592
New +$122K 0.01% 94

Other funds holding MRK

QVR's MRK Position: Q2 2026 in Review

QVR sold out of Merck (MRK) in Q2 2026, closing a stake of 13,715 shares — an estimated $1.65M sold.

QVR first reported a position in MRK in Q4 2020 and held it in 6 quarters. The position peaked at $2.49M in Q4 2025. 711 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • QVR reported no remaining Merck position as of Q2 2026 after selling out during the quarter.
  • QVR sold 13,715 Merck shares in Q2 2026, an estimated $1.65M.
  • QVR first reported a position in Merck in Q4 2020 and held it in 6 quarters.
  • QVR's Merck position peaked at $2.49M in Q4 2025.
  • 711 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on QVR's 13F filing for Q2 2026.